from Google Alert at http://bit.ly/2faWYFe on October 31, 2016 at 03:46PM The session was moderated by Andrew Briggs, DPhil, William R. Lindsay Chair of Health Economics, Health Economics and Health Technology …
from Healthcare Economist at http://bit.ly/2f6xQAI on October 31, 2016 at 03:13PM The Healthcare Economist on NPR Written By: Jason Shafrin – Oct• 31•16 Check out my interview on NPR with Here & Now’s Jeremy Hobson about what recent changes in health insurance premiums changes mean for the future of the Affordable Care Act. http://bit.ly/2foqUme
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2eg9INj on October 31, 2016 at 02:52PM This report addresses the following questions: How do access restrictions for multiple myeloma drugs differ across markets and why? Which clinical trial comparators and outcomes are necessary for approval and uptake in each market? What impact, if any, will value assessment […]
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2eg9Tbn on October 31, 2016 at 02:52PM This report addresses the following questions: – What impact have CER and HEOR had on drug reimbursement and uptake in the US so far? – Who are the key generators and users of CER and HEOR data? – How are new […]
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2f6unBZ on October 31, 2016 at 02:22PM Chronic illnesses are highly prevalent in the United States, but many can be effectively controlled with medication. The trick is making sure patients are taking their medications as directed. Read here. (Source: Seth A. Seabury, JMCP, November 2016)
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2f2dvin on October 31, 2016 at 01:51PM Sales of drugs that use a novel mechanism to reduce cholesterol levels have remained flat amid prescriber and payer skepticism, despite high spending on promotional campaigns by the drugs’ makers. Read more here. (Source: Damian Garde, STAT, 10/28/16)
from The Incidental Economist at http://bit.ly/2espRwH on October 31, 2016 at 12:59PM It’s the systematic review everyone who writes about food has been waiting for I only wish I had the time and focus to do this myself. Instead, hats off to Nicholas Chartres, Alice Fabbri, and Lisa A. Bero. From JAMA Internal Medicine, “Association of […]
from Google Alert at http://bit.ly/2f20HIU on October 31, 2016 at 12:45PM Here & Now’s Jeremy Hobson talks with Jason Shafrin, senior research economist at Precision Health Economics, about what the changes mean for …
from Google Alert at http://bit.ly/2eUVQGa on October 31, 2016 at 12:45PM Pagán is a former Robert Wood Johnson Foundation Health & Society Scholar with expertise in health economics and health services research.
from ISPOR News & Press Releases at http://bit.ly/2esmlSR on October 31, 2016 at 12:05PM Vienna, Austria—31 October 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) led an interesting discussion session this afternoon entitled, From Testimonials to Qualitative Research Embedded in Clinical Trials: How Do Health Technology Assessment Bodies Consider the Voice of Rare Disease […]
from ISPOR News & Press Releases at http://bit.ly/2dVRNwN on October 31, 2016 at 12:05PM Vienna, Austria—31 October 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held a workshop this afternoon on New Approaches to Survival Modeling in Oncology at the Society’s 19th Annual European Congress in Vienna, Austria. The session was moderated by Andrew […]
from Google Alert at http://bit.ly/2eUEfyn on October 31, 2016 at 11:24AM Princeton University health economist Uwe Reinhardt said some insurance companies underpriced their policies either to grab market share under …
from Google Alert at http://bit.ly/2f1EMRO on October 31, 2016 at 11:24AM Austin Frakt is a health economist with several governmental and academic affiliations. He blogs at The Incidental Economist, and you can follow him …
from CCHE General Updates Archive Feed at http://bit.ly/2fa3jka on October 31, 2016 at 10:16AM Canadian Centre for Health Economics View this email in your browser Dear All, As part of the Canadian Centre for Health Economics (CCHE) Friday Health Economics Series, we welcome Peter Austin this Friday November 4th, 10am – 12pm in HS100 (Health […]
from PeterUbel.com at http://bit.ly/2eMTX0W on October 31, 2016 at 10:01AM According to recent research, a hug a day could keep the doctor away. According to another study, twitter can predict the chance that people will experience heart attacks. A normal blogger would look at these two findings and tell a story about the relationship between […]
from PeterUbel.com at http://bit.ly/2eMRYcK on October 31, 2016 at 10:01AM Diabetes is a dangerous disease, putting people at risk for heart attack, stroke, kidney failure, blindness, amputation…plenty of serious stuff. Fortunately, pills and injections can reduce blood sugar and thereby reduce the risk of those awful sequels. Unfortunately, doctors sometimes treat blood sugar too aggressively, […]
from ISPOR News & Press Releases at http://bit.ly/2f9Rmeq on October 31, 2016 at 09:05AM Vienna, Austria—31 October 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) facilitated a discussion on National Health Technology Assessment (HTA) Process and European Cooperation on HTA: Fit for Purpose? this morning at the Society’s 19th Annual European Congress in Vienna, […]
from ISPOR News & Press Releases at http://bit.ly/2efbrSH on October 31, 2016 at 09:05AM Building Collaboration Between Regulators and Health Technology Assessment Bodies Vienna, Austria—31 October 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) opened its 19th Annual European Congress in Vienna, Austria this morning with the first plenary session, What Synergies Could Be […]
from The Incidental Economist at http://bit.ly/2erxZh2 on October 31, 2016 at 08:27AM Healthcare Triage: Can Yelp Reviews Help Improve Patient Care? Hospitals and many insurance carriers care about patient satisfaction. It especially matters to hospitals because insurance payments can be influenced by how patients rate the care they receive, as well as by the health […]
from THCB at http://bit.ly/2f4PEMV on October 31, 2016 at 08:10AM By CAITLIN BREANNE SMITH It’s been established that an effective way to manage an individual’s health is to address the root cause of health complications, known as social determinants of health (SDOH). Unfortunately, interventions that address SDOH often exist outside the scope of the traditional […]
from The Incidental Economist at http://bit.ly/2er4eN3 on October 31, 2016 at 06:27AM Help me learn new things! – Chaos Theory This post is part of a series in which I’m dedicating a month to learning about twelve new things this year. The full schedule can be found here. This is month nine/ten. (tl;dr at the bottom […]
from Market Design at http://bit.ly/2e4Rfji on October 31, 2016 at 05:40AM The Ottawa Sun has the story: After Eugene Melnyk, transplant surgeons OK public appeals for living organ donors "Eighteen months after a donated liver from a stranger saved the life of Ottawa Senators owner Eugene Melnyk, his case has helped prompt Canadian transplant officials to […]
from The Academic Health Economists’ Blo… at http://bit.ly/2eTyXDa on October 31, 2016 at 05:02AM Every Monday our authors provide a round-up of some of the most recently published peer reviewed articles from the field. We don’t cover everything, or even what’s most important – just a few papers that have interested the author. Visit our Resources page […]
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2eeic7l on October 31, 2016 at 04:49AM Sen Bernie Sanders is out put an end to the greedy pricing practices of the pharmaceutical companies. He recently brought Canada into the debate as he contrasted the priced differences between the two countries and discussed importing prescription drugs from Canada. […]
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2e4ATai on October 31, 2016 at 04:19AM Get caught up on the latest issue of hat Quarterly, Examine rapid access in the U.S., UK, and France, targeted therapies for psoriasis and psoriatic arthritis, and explore Singapore’s highly efficient healthcare system. Read now. (Source: Xcenda AmerisourceBergen, HTA Quarterly, Fall […]
from The Incidental Economist at http://bit.ly/2dUGQv8 on October 31, 2016 at 04:14AM Pharmacists Can Provide the Right Prescription for a Projected Crisis in Health Care, RealClearHealth Americans Fed Up With Soaring Drug Prices: HealthDay/Harris Poll, RealClearHealth What is this post about? Look here. @afrakt
from Health Economics and Decision Science Blog @ ScHARR at http://bit.ly/2f3UVEn on October 31, 2016 at 03:38AM Visit us at: Exhibition Booth 20/21 HEDS has a lively schedule at the ISPOR 19TH European Annual Congress currently being held in Vienna . Ten members of the HEDS team will contribute to the conference programme. Paul Tappenden […]
from Health Economics and Decision Science Blog @ ScHARR at http://bit.ly/2epXa3w on October 30, 2016 at 11:00PM ….is almost complete. The website now lists protocols and methodology papers, but we’ll just flag up the notable reviews…well, notable to our work; these being…… Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its […]
from Healthcare Economist at http://bit.ly/2fv1yCz on October 30, 2016 at 08:50PM The value of adherence information Written By: Jason Shafrin – Oct• 30•16 A study titled “Estimating the Value of New Technologies That Provide More Accurate Drug Adherence Information to Providers for Their Patients with Schizophrenia” was just published in the November edition of JMCP. This […]
from Health Economics at http://bit.ly/2f2OJMB on October 30, 2016 at 11:09AM This paper investigates the impact of the Paid Family Leave (PFL) Act of California on the timing of first births for mothers, as well as infant health outcomes. Using a Difference in Difference (DID) methodology and Vital Statistics data from National Center for Health […]
from Health Economics at http://bit.ly/2fkfGiv on October 30, 2016 at 11:09AM This paper examines the impact of breastfeeding on early childhood outcomes. Using Birth Cohort of Early Childhood Longitudinal Survey data and employing a recently developed econometric technique, we estimate the upper and lower bounds of the effect of breastfeeding on early childhood health and […]
from Health Economics at http://bit.ly/2f2OrFh on October 30, 2016 at 11:09AM The primary goal of the KidsWell Campaign was to ensure access to health insurance for all children, which in turn was expected to lead to improved health outcomes. KidsWell sought to achieve this aim through a two-fold strategy: by protecting and expanding children’s health […]
from Health Economics at http://bit.ly/2fkixYP on October 30, 2016 at 11:09AM When the Patient Protection and Affordable Care Act (ACA) passed in 2010, about 6.2 million children were uninsured; of those, nearly 70 percent were already eligible for coverage through Medicaid or the Children’s Health Insurance Program (CHIP) but not enrolled (Kenney et al. 2012). […]
from Health Economics at http://bit.ly/2f2NAom on October 30, 2016 at 11:09AM The Cities Expanding Health Access for Children and Families (CEHACF) project was designed to capitalize on both cities’ responsibility for protecting the health and well-being of their residents and municipal leaders’ platform for engaging residents. The project’s overarching goal was to empower municipal leaders […]
from Health Economics at http://bit.ly/2fkeTyj on October 30, 2016 at 11:09AM Individuals face significant late-in-life risks, including needing long-term care (LTC). Yet, they hold little long-term care insurance (LTCI). Using both “strategic survey questions,” which identify preferences, and stated demand questions, this paper investigates the degree to which a fundamental lack of interest and poor […]
from Health Economics at http://bit.ly/2f2P1CU on October 30, 2016 at 11:09AM One of the key terms in contracts between hospitals and insurers is how the parties apportion the financial risk of treating unexpectedly costly patients. “Prospective” payment contracts give hospitals a lump-sum amount, depending on the medical condition of the patient, with limited adjustment for […]
from Health Economics at http://bit.ly/2fkky7d on October 30, 2016 at 11:09AM The U.S. 2009 Tobacco Control Act opened the door for new anti-smoking policies by giving the Food and Drug Administration broad regulatory authority over the tobacco industry. We develop a behavioral welfare economics approach to conduct cost-benefit analysis of FDA tobacco regulations. We use […]
from Health Economics at http://bit.ly/2f2Pkhd on October 30, 2016 at 11:09AM Activists criticize the poor wages and working conditions in industrial firms. Others counter that these industrial jobs offer wage premiums and steady hours. We worked with five Ethiopian industrial firms to randomize entry-level applicants to one of three treatment arms: a job offer; a […]
from Health Economics at http://bit.ly/2fkhiZu on October 30, 2016 at 11:09AM This paper exploits longitudinal insurance claims data and a cost-sharing subsidy that has exempted copayment and coinsurance of healthcare services for children under the age of 3 in Taiwan. We use a regression discontinuity design to estimate its effect on children’s healthcare utilization. Our […]
from Health Economics at http://bit.ly/2f2NpJu on October 30, 2016 at 11:09AM We investigate the causal impact of retirement on health care utilization. Using SHARE data (from 2004 to 2013) for 10 European countries, we show that health care utilization increases when individuals retire. This is true both for the number of doctor’s visits and for […]
Health Econ Bot 
You must be logged in to post a comment.